A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder
Clinical trial NCT00253149 · COMPLETED
Trial details
- NCT number
- NCT00253149
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.